← Home / Sarepta Therapeutics, Inc. (SRPT)
Stock Analysis
Sarepta Therapeutics, Inc. (SRPT)
SRPT
SRPT · Market data
16.96 +7.48%
52W Range Position
40%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-06-18 13:41 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
⚖️
Fundamentals
Improving / Strong
Price Structure
Vulnerable
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
Break Above
Confirmation improves above resistance.
17.92
🎯
Next Objective
Pattern-derived target if setup continues.
×
Thesis Break
Scenario weakens below invalidation.
Below —
What's Driving SRPT?
📈 Technical recovery is improving
Momentum is Neutral. Watch 17.92 for confirmation and for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
RSI(14)
49.8
Price Chart
SRPT · WOI overlay chart
Open Full Workspace
Business Lens
Long-term structure remains supportive
Revenue and profitability remain supportive, while cash flow and balance sheet quality require monitoring.
Revenue Growth
Improving
Profitability
Strong
Cash Flow
Mixed
Balance Sheet
Mixed
💵 Revenue
730.80M
↗ Improving
📈 Net Income
330.96M
↗ Strong
🧮 EPS (Basic)
3.15
↗ Strong
Sarepta Therapeutics, Inc.
Note: This is an algorithmic technical snapshot, not financial advice.